We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAVI:BISTMavi Giyim Sanayi ve Ticaret A.S. Analysis

Data as of 2026-06-18 - not real-time

TRY 42.14

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Mavi Giyim is trading around the 42 TRY mark, just above its 20‑day SMA and below the 50‑day SMA, with a neutral RSI in the mid‑40s and a bearish MACD histogram, suggesting limited upside momentum in the near term. The stock’s beta of roughly 0.26 indicates low sensitivity to broader market moves, yet the 30‑day volatility exceeds 35%, reflecting sharp price swings and a heightened short‑term risk profile.
Fundamentally, the company delivers strong top‑line growth of about 24% YoY, solid gross margins above 50%, and a healthy free cash flow generation, while the DCF‑derived fair value of over 100 TRY points to a substantial valuation gap. The dividend yield near 4% is attractive, but a payout ratio above 100% raises sustainability concerns. Analyst consensus leans heavily toward a strong‑buy, with a median price target near 65 TRY, underscoring the perception of significant upside despite macro‑economic headwinds in Turkey.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram indicating short‑term downside pressure
  • Proximity to the identified support level around 39.5 TRY
  • Elevated 30‑day volatility amplifying price swing risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation upside implied by DCF fair value over 100 TRY
  • Robust revenue growth and strong operating cash flow generation
  • Attractive dividend yield despite payout concerns

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable competitive positioning in the apparel retail segment
  • Consistent profitability metrics (ROE ~11%, ROA ~12%)
  • Long‑run macro‑economic recovery potential in Turkey boosting consumer spending

Key Metrics & Analysis

Financial Health

Revenue Growth23.70%
Profit Margin3.94%
P/E Ratio17.9
ROE11.07%
ROA12.21%
Debt/Equity34.62
P/B Ratio2.4
Op. Cash FlowTRY8.2B
Free Cash FlowTRY2.4B

Technical Analysis

TrendNeutral
RSI46.9
SupportTRY 39.52
ResistanceTRY 45.10
MA 20TRY 42.23
MA 50TRY 43.00
MA 200TRY 42.12
MACDBearish
VolumeIncreasing
Fear & Greed Index88.5

Valuation

Fair ValueTRY 109.33
Target PriceTRY 64.78
Upside/Downside53.74%
GradeUndervalued
TypeBlend
Dividend Yield3.99%

Risk Assessment

Beta0.26
Volatility35.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.